OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Advent of Molecular Targeted Therapies Against Cancer. Toward Multi‐Targeting Drugs Through Materials Engineering: A Possible Future Scenario
Marianna Puzzo, Marzia De Santo, Catia Morelli, et al.
Small Science (2024) Vol. 4, Iss. 8
Open Access | Times Cited: 9
Marianna Puzzo, Marzia De Santo, Catia Morelli, et al.
Small Science (2024) Vol. 4, Iss. 8
Open Access | Times Cited: 9
Showing 9 citing articles:
Colorectal Cancer: Current and Future Therapeutic Approaches and Related Technologies Addressing Multidrug Against Multiple Level Resistance Mechanisms
Marianna Puzzo, Marzia De Santo, Catia Morelli, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1313-1313
Open Access | Times Cited: 1
Marianna Puzzo, Marzia De Santo, Catia Morelli, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1313-1313
Open Access | Times Cited: 1
Prostate cancer chemotherapy by intratumoral administration of Docetaxel-Mesoporous silica nanomedicines
Eva Rivero‐Buceta, Adrián Bernal-Gómez, Carla Vidaurre-Agut, et al.
International Journal of Pharmaceutics (2024) Vol. 664, pp. 124623-124623
Open Access | Times Cited: 4
Eva Rivero‐Buceta, Adrián Bernal-Gómez, Carla Vidaurre-Agut, et al.
International Journal of Pharmaceutics (2024) Vol. 664, pp. 124623-124623
Open Access | Times Cited: 4
Redefining Hepatocellular Carcinoma Treatment: Nanotechnology Meets Tumor Immune Microenvironment
Chen Mi, Sai Liu, Zhida Chen
Journal of drug targeting (2025), pp. 1-47
Closed Access
Chen Mi, Sai Liu, Zhida Chen
Journal of drug targeting (2025), pp. 1-47
Closed Access
Design, Synthesis, and Evaluation of Cytotoxic Effects of Functional Fatty Acid Derivatives as Potential Antineoplastic Agents for Breast Cancer
Maryam Hosseini, Farzad Kobarfard, Salimeh Amidi, et al.
Deleted Journal (2025) Vol. 24, Iss. 1
Open Access
Maryam Hosseini, Farzad Kobarfard, Salimeh Amidi, et al.
Deleted Journal (2025) Vol. 24, Iss. 1
Open Access
A novel approach for the co-delivery of 5-fluorouracil and everolimus for breast cancer combination therapy: stimuli-responsive chitosan hydrogel embedded with mesoporous silica nanoparticles
Pooria Mohammadi Arvejeh, Fatemeh Amini Chermahini, Francesco M. Marincola, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Pooria Mohammadi Arvejeh, Fatemeh Amini Chermahini, Francesco M. Marincola, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Design, synthesis, and antiproliferative screening of new quinoline derivatives bearing a cis-vinyl triamide motif as apoptosis activators and EGFR-TK inhibitors
Hany M. Abd El‐Lateef, Ahmed Gaafar Ahmed Gaafar, Arwa Sultan Alqahtani, et al.
RSC Advances (2024) Vol. 14, Iss. 34, pp. 24781-24790
Open Access | Times Cited: 3
Hany M. Abd El‐Lateef, Ahmed Gaafar Ahmed Gaafar, Arwa Sultan Alqahtani, et al.
RSC Advances (2024) Vol. 14, Iss. 34, pp. 24781-24790
Open Access | Times Cited: 3
Engineered Mesoporous Silica-Based Nanoparticles: Characterization of Surface Properties
Antonio Grisolia, Marzia De Santo, Manuela Curcio, et al.
Materials (2024) Vol. 17, Iss. 13, pp. 3352-3352
Open Access | Times Cited: 2
Antonio Grisolia, Marzia De Santo, Manuela Curcio, et al.
Materials (2024) Vol. 17, Iss. 13, pp. 3352-3352
Open Access | Times Cited: 2
Nanotechnology in Advancing Chimeric Antigen Receptor T Cell Therapy for Cancer Treatment
Xuejia Kang, Nur Mita, Lang Zhou, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1228-1228
Open Access | Times Cited: 2
Xuejia Kang, Nur Mita, Lang Zhou, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1228-1228
Open Access | Times Cited: 2
Bufalin Suppresses Head and Neck Cancer Development by Modulating Immune Responses and Targeting the β-Catenin Signaling Pathway
Nour Mhaidly, Noura Barake, Anne Trelcat, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2739-2739
Open Access
Nour Mhaidly, Noura Barake, Anne Trelcat, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2739-2739
Open Access
